Bromide

Bromide

SCHEMBL11003437

Br.Br.CC(N)CSCc1nccs1

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ SLC6A3 known ✓ Q01959 3/20 0.33
▸ FDPS P14324 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ NOS1 P29475 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ FBP1 P09467 2/20 0.32
▸ CYP2C19 P33261 1/20 0.31
▸ PDK1 Q15118 1/20 0.31
▸ HTR7 P34969 1/20 0.30
▸ MAOA P21397 1/20 0.30
▸ MAOB P27338 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11002316 0.98 FDPS (0.37) FDPSSLC6A3ALDH1A1TSHRNOS1
SCHEMBL3407472 0.74 — —
SCHEMBL12854060 0.74 — —
Bromide SCHEMBL11292435 0.74 FDPS (0.39) FDPSSLC6A3ALDH1A1TSHRNOS1
SCHEMBL10736773 0.72 FDPS (0.40) FDPSSLC6A3ALDH1A1TSHRNOS1
SCHEMBL10425543 0.71 FDPS (0.37) FDPSSLC6A3ALDH1A1TSHRNOS1
Hydrochloric Acid SCHEMBL11728035 0.70 L3MBTL1 (0.40) FDPSSLC6A3ALDH1A1TSHRNOS1
SCHEMBL11445384 0.69 FDPS (0.42) FDPSSLC6A3ALDH1A1TSHRNOS1
SCHEMBL9084618 0.69 KMT2A (0.45) FDPSALDH1A1TSHRNOS1HSD17B10
SCHEMBL10425542 0.69 FDPS (0.38) FDPSSLC6A3ALDH1A1TSHRNOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4499101-A HISTAMINE H2-ANTAGONISTS; ANTISECRETORY ANTIINFLAMMOATORY AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1985-02-12 — — US disclosed
US-4388319-A ANTIHISTAMINES, ANTISECRETORY, ANTIINFLAMMATORY, HYPOTENSIVE AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1983-06-14 — — US disclosed
US-4271169-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1981-06-02 — — US disclosed
US-4215125-A H-2 HISTAMINE RECEPTOR INHIBITORS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-07-29 — — US disclosed
US-4152443-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1979-05-01 — — US disclosed
US-4112104-A UREA, THIOUREA OR GUANIDINE DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1978-09-05 — — US disclosed
US-4025527-A H-2 HISTAMINE RECEPTOR INHIBITORS SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-05-24 — — US disclosed
Send feedback